Shuaijie Dou1,2?, Guoxian Li1,3?, Ge Li1?, Chunmei Hou1, Yang Zheng4, Lili Tang1, Yang Gao1, Rongliang Mo1, Yuxiang Li1, Renxi Wang1,5*, Beifen Shen1, Jun Zhang3*, Gencheng Han1*
軍事科學(xué)院軍事醫(yī)學(xué)研究院韓根成研究員,河南大學(xué)醫(yī)學(xué)院張軍教授,首都醫(yī)科大學(xué)王仁喜教授
1 Beijing Institute of Basic Medical Sciences, Beijing, China;
2 Anhui Medical University, Hefei, China;
3 Institute of Immunology, Medical School of Henan University, Kaifeng, China;
4 Department of Oncology, First Hospital of Jilin University, Changchun, China;
5 Beijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical University, Beijing, China
? These authors contributed equally to this work